Chargement en cours...
Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants
PURPOSE: More than a third of primary breast cancer patients are treated with cytotoxic chemotherapy, typically without guidance from predictive markers. Increased use of neoadjuvant chemotherapy provides opportunities for identification of molecules associated with treatment response, by comparing...
Enregistré dans:
| Publié dans: | Breast Cancer Res Treat |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer US
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497675/ https://ncbi.nlm.nih.gov/pubmed/32734521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05836-7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|